Tofacitinib Sitrat CAS 540737-29-9

Deskripsyon pwodwi:

Non pwodwi: Tofacitinib sitrat CAS NON: 540737-29-9

Sinonim:

3 - ((3R, 4R) -4-methyl-3- (methyl (7H-pyrrolo [2,3-d] pyrimidin-4-yl) amino) piperidin-1-il) -3-oxopropanenitrile 2-hydroxypropane- 1,2,3-trikarboksilat;

Tofacitinibcitrate;

2-hydroxypropane-1,2,3-tricarboxylic asid, 3 - [(3R, 4R) -4-methyl-3- [methyl (7H-pyrrolo [2,3-d] pirimidin-4-il) amino] piperidin -1-yl] -3-oxopropanenitrile;

Chimik& Pwopriyete fizik:

Aparans: Blan poud bèj

Egzamen: ≥99.0%

Pwen fizyon: 201 ℃ (dekonpoze)

Tanp Depo .: Tanperati chanm lan

Solitid: DMSO: idrosolubl 5mg / mL (solisyon klè; chofe)

Enfòmasyon sou sekirite:

WGK Almay: 3

HS Kòd: 29335990

CP-690550 se yon dérivés pyrrolo [2,3-d] pirimidin, tankou Janus kinase inibitè pou tretman atrit rimatoyid. Torfacitinib sitrat ka itilize nan konbinezon ak metotreksat pou tretman nan atrit rimatoyid aktif ak repons apwopriye a timè faktè nekwoz inhibiteurs. Nan esè klinik yo, reyaksyon negatif ki pi komen nan sitrat tofacitinib te enfeksyon nan aparèy respiratwa anwo, maltèt, dyare, konjesyon nan nen, gòj fè mal, ak nasofaringit.

Si ou enterese nan pwodwi nou yo oswa ou gen nenpòt kesyon, tanpri ou lib pou kontakte nou!

Pwodwi anba patant yo ofri pou R& D objektif sèlman. Sepandan, responsablite final la manti sèlman ak achtè a.

Baj popilè: tofacitinib citrate cas 540737-29-9, manifaktirè, founisè, faktori, achte, nan stock

• On: (1R, 5S, 6S) -6- [1 (R) -Hydroxyethyl] -1-methyl-2- [1- (2-thiazolin-2-yl) azetidin-3-ylsulfanyl] -1-carba-2- penem-3-karboksilik asid Pivaloyloxymethyl Ester CAS 161715-24-8
• Pwochen: Azilsartan CAS 147403-03-0